ERBB2 and breast carcinoma: In breast cancer, there are several publications, which direct towards this yet unclear issue of Her2/CEP17 polysomy in terms of determination of true Her2 status, and there is increasing evidence that Her2/CEP17 polysomy represents rather a phenomenon of co-amplification than true polysomy [37–39].